TGFB1 and breast cancer: The pronounced secretion of TGFβ1 by CAFs in breast cancer promotes an aggressive phenotype in tumor cells also through direct activation of EMT, with decreased expression of E-CADHERIN and over-expression of VIMENTIN, Fibronectin1 (FN1), MMP2 and MMP9 [43].